Teva Pharmaceutical Industries Newswire

Comprehensive Real-Time News Feed for Teva Pharmaceutical Industries.

Results 1 - 20 of 1,156 in Teva Pharmaceutical Industries

  1. Teva Pharmaceutical Industries LtdRead the original story w/Photo

    9 hrs ago | AmericanBankingNews.com

    Teva Pharmaceutical Industries Ltd announced a quarterly dividend on Friday, August 1st, Analyst Ratings Network reports.

    Comment?

  2. Teva Pharmaceutical Industries' (TEVA) CEO Erez Vigodman on Q2 2014...Read the original story

    Thursday | Seeking Alpha

    At this time, all participants are in a listen only mode. There will be a presentation followed by a question-and-answer session.

    Comment?

  3. Teva earnings rise on growing generic drug salesRead the original story

    Thursday | Modern Healthcare

    Strong U.S. and international sales of its generic drugs sent second-quarter earnings higher for Israeli-based Teva Pharmaceutical Industries, the world's largest generic drugmaker.

    Comment?

  4. Teva Raises Forecast as Profit Beats Estimates on GenericsRead the original story

    Thursday | The Washington Post

    Teva Pharmaceutical Industries Ltd. raised its profit forecast and reported second-quarter earnings that beat estimates as its generic division cut costs and a new version of the bestselling Copaxone drug gained traction.

    Comment?

  5. Why Teva Pharmaceutical (TEVA) Stock Is Lower TodayRead the original story w/Photo

    Thursday | TheStreet.com

    Profit excluding some costs was up 4% to $1.05 billion, or $1.23 a share, from $1.02 billion, or $1.20 a share, a year ago, the company said.

    Comment?

  6. UPDATE 1-Teva Pharm raises full-year profit forecast after solid second quarterRead the original story

    Thursday | Reuters

    Teva Pharmaceutical Industries raised its full-year profit forecast on Thursday after posting higher quarterly earnings that were due in part to the launch of several generic products in the United States.

    Comment?

  7. Teva Pharm shareholder optimistic of change despite losing voteRead the original story

    Thursday | Reuters

    Israeli industrialist Benny Landa said his campaign to improve corporate governance at Teva Pharmaceutical Industries was delivering results, despite losing a shareholder vote at the world's largest generic drugmaker.

    Comment?

  8. Teva Pharmaceutical Swings to a ProfitRead the original story

    Thursday | Wall Street Journal

    Teva Pharmaceutical Industries Ltd. said its swung to a profit in the second quarter, driven by strong gains in its generic medicine sales.

    Comment?

  9. All Proposals Approved At Teva Pharmaceutical Industries Limited's Annual Meeting Of ShareholdersRead the original story

    Thursday | BioSpace

    Teva Pharmaceutical Industries Ltd. announced that all proposals were approved at its Annual General Meeting of Shareholders held earlier today.

    Comment?

  10. Teva Pharmaceutical Industries Limited Reports Second Quarter 2014 ResultsRead the original story

    Thursday | BioSpace

    Teva Pharmaceutical Industries Ltd. today reported results for the quarter ended June 30, 2014.

    Comment?

  11. Teva Second-Quarter Profit Rises on New Version of MS MedicineRead the original story

    Thursday | The Washington Post

    Teva Pharmaceutical Industries Ltd.'s raised its profit forecast and reported second-quarter earnings that beat analyst estimates as the company converted patients to a longer-acting version of the branded multiple sclerosis treatment Copaxone.

    Comment?

  12. Teva Pharm Q2 profit, revenue up on generic launchesRead the original story

    Thursday | Reuters

    Teva Pharmaceutical Industries reported on Thursday higher quarterly earnings that beat analysts' estimates by one cent due in part to the launch of several generic products in the United States.

    Comment?

  13. Antares Pharma to Host Second Quarter 2014 Operating and Financial Results Conference CallRead the original story

    Thursday | Business Wire

    ... multi-use pen injectors and reusable needle-free injectors marketed as TjetA and ZomajetA by Teva Pharmaceutical Industries, Ltd (Teva) and Ferring Pharmaceuticals (Ferring), respectively. Antares Pharma has a multi-product deal with Teva that ...

    Comment?

  14. Teva Activist Claims Symbolic Win as Directors Pressured in VoteRead the original story

    Wednesday Jul 30 | The Washington Post

    An activist investor calling for change at Teva Pharmaceutical Industries Ltd. said the result of a shareholder vote to reappoint all board members is a victory, and that the level of dissent shows the company will have to listen to stockholders.

    Comment?

  15. Teva Shareholders Back Directors Targeted by DissidentsRead the original story

    Wednesday Jul 30 | Wall Street Journal

    Shareholders of Teva Pharmaceutical Industries Ltd. voted in favor of all of management's proposals at the company's annual meeting, the Israeli drug maker said Wednesday.

    Comment?

  16. Novartis: The Case Of The Undervalued Biosimilar PioneerRead the original story w/Photo

    Wednesday Jul 30 | Seeking Alpha

    Most investors, specially when they start looking at this sector, find themselves overwhelmed with information and technical jargon.

    Comment?

  17. Teva says shareholders favor management as shakeup fizzlesRead the original story

    Wednesday Jul 30 | Reuters

    Israeli drugmaker Teva Pharmaceuticals Industries said on Wednesday it turned back efforts by Israeli industrialist Benny Landa to shake up the company's board of directors, with shareholders approving all of the company's proposals and board nominations.

    Comment?

  18. Press release distribution, EDGAR filing, XBRL, regulatory filingsRead the original story

    Wednesday Jul 30 | Business Wire

    ... LLP, a law firm that represents investors in securities class actions. The firm is ... )--Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) announced that all proposals were approved at its Annual General Meeting of Shareholders held earlier today. ...

    Comment?

  19. All Proposals Approved at Teva's Annual Meeting of ShareholdersRead the original story

    Wednesday Jul 30 | Hispanic Business

    These proposals included the appointment of directors, the approval of cash bonus objectives and future equity awards for the Chief Executive Officer, directors' and officers' insurance and the appointment of auditors.

    Comment?

  20. Teva Pharmaceutical Industries EPS Estimates Improved In Past MonthRead the original story w/Photo

    Wednesday Jul 30 | Forbes.com

    Leading up to Teva Pharmaceutical Industries' announcement of its second-quarter earnings on Thursday, July 31, 2014, analysts have become more bullish as expectations have improved over the past month from $1.17 per share to the current projection of earnings of $1.22 per share.

    Comment?